Reduced dosage of tenecteplase in elderly patients undergoing a pharmaco-invasive strategy. Delays in achieving timely reperfusion in patients with acute coronary syndrome with ST elevation (STEACS), whether through fibrinolysis or primary percutaneous coronary intervention (PCI), are associated with increased mortality. European guidelines establish a target reperfusion time of 120 minutes after the first medical contact...
International Joint Sessions at SOLACI-SBHCI 2023
The most important Scientific Societies in the world will be present at the SOLACI-SBHCI 2023 Congress. Discover them below.
ProEducar-SOLACI Fellows Course 2023 – Participate for a grant for the SCAI Fellows Course
For the thirteenth consecutive year, we will be hosting an educational excellence course for interventionalists in training from Latin America: the ProEducar-SOLACI Fellows Course. This one-day intensive course covers the most important topics in interventional cardiology with a practical focus. 5 Thematic Modules At the end of the course, there will be a optional final exam....
ABSORB IV – Improving Bioresorbable Scaffolds: A Long Road
5-year followup of bioresorbable scaffolds in selected and better prepared lesions (ABSORB IV). Historically, when comparing previously used therapies, such as conventional balloon angioplasty (BA) against bare metal stent (BMS) and later against drug eluting stent (DES) implantation, we see significantly improved outcomes. These advances have shown reduced recoil and more effective restenosis inhibition, compared...
Simplified Rapid Intravenous Hydration for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease
Patients with chronic kidney disease (CKD) undergoing coronary angiography are at increased risk of developing contrast-associated acute kidney injury (CA-AKI), which is associated with increased mortality. According to current guidelines, the standard treatment for preventing CA-AKI in patients with moderate to severe CKD is long-duration peri-procedural intravenous hydration with saline solution. This standard hydration is...
Opportunity for Fellows! 1 Year Training Program from McMaster University (Canada) – SOLACI Invitation
McMaster University in Canada, is developing a 1-year training program on imaging guided percutaneous coronary intervention (non-invasive cardiac CT, IVUS and OCT). From SOLACI, we extend the invitation to all Latin American fellows, since we consider this a unique opportunity to apply and be able to advance your careers in such a renowned institution of...
TAVR Durability at 5 Years in Intermediate Risk Patients
TAVR has been shown beneficial in patients across the risk spectrum. The PARTNER 2 SAPIEN 3 (P2S3i) study on intermediate risk patients was the first to show TAVR superiority vs SAVR when using the transfemoral approach. SAVR durability has been shown in different analysis but, except for a few reports, TAVR durability at long term...
Relationship between Distal Vessel Quality and Outcomes in the Treatment of Chronic Total Occlusions
Percutaneous treatment of chronic total occlusions has increase, and has become a a more habitual therapeutic challenge. However, there is limited information on distal vessel quality and its association with outcomes and techniques. This variable appears to be excluded form CTO scores, except for the RECHARGE (REgistry of CrossBoss and Hybrid procedures in FrAnce, the...
Transcatheter Mitral Valve Replacement vs. Medical Therapy
Mitral valve regurgitation (MR) is a common cause behind heart failure and is associated to hospitalization for heart failure and higher mortality. Transcatheter edge-to-edge repair (TEER), together with guideline-directed medical therapy (GDMT) has been shown beneficial in high risk patients, according to the COAPT study. However, there is a significant group of patients that make...
Aortic Stenosis and Cardiogenic Shock: Is TAVR an Option?
Cardiogenic shock (CS) in a setting of aortic stenosis is associated with high mortality rates. In consequence, surgery is generally not a possibility for this patient group, and they usually undergo aortic valvuloplasty, resulting in a mortality rate of 33%-50% at 30 days, 70% at one year, and 90% at two years. While transcatheter aortic...